Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests ; volume:6 ; number:1 ; day:17 ; month:10 ; year:2011 ; pages:1-10 ; date:12.2011
Orphanet journal of rare diseases ; 6, Heft 1 (17.10.2011), 1-10, 12.2011
- Creator
-
Andreotti, Giuseppina
- Contributor
-
Citro, Valentina
De Crescenzo, Agostina
Orlando, Pierangelo
Cammisa, Marco
Correra, Antonella
Cubellis, Maria Vittoria
SpringerLink (Online service)
- DOI
-
10.1186/1750-1172-6-66
- URN
-
urn:nbn:de:1111-2016050119712
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Andreotti, Giuseppina
- Citro, Valentina
- De Crescenzo, Agostina
- Orlando, Pierangelo
- Cammisa, Marco
- Correra, Antonella
- Cubellis, Maria Vittoria
- SpringerLink (Online service)
Other Objects (12)
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Drug repositioning can accelerate discovery of pharmacological chaperones
Targeted stabilization of Munc18‐1 function via pharmacological chaperones
Light‐Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological Chaperones
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
Molecular chaperones
Phosphorus Dendrimers for Metal‐Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease
Development of a pharmacorphore model for pharmacological chaperones targeting mutant trafficking-deficient CNG channels
Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study
Pharmacological Chaperones for β‐Galactosidase Related to G M1 ‐Gangliosidosis and Morquio B: Recent Advances
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Drug repositioning can accelerate discovery of pharmacological chaperones
Targeted stabilization of Munc18‐1 function via pharmacological chaperones
Light‐Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological Chaperones
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
Molecular chaperones
Phosphorus Dendrimers for Metal‐Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease
Development of a pharmacorphore model for pharmacological chaperones targeting mutant trafficking-deficient CNG channels
Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study
Pharmacological Chaperones for β‐Galactosidase Related to G M1 ‐Gangliosidosis and Morquio B: Recent Advances
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Drug repositioning can accelerate discovery of pharmacological chaperones
Targeted stabilization of Munc18‐1 function via pharmacological chaperones
Light‐Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological Chaperones
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
Molecular chaperones
Phosphorus Dendrimers for Metal‐Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease
Development of a pharmacorphore model for pharmacological chaperones targeting mutant trafficking-deficient CNG channels
Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study